JP2024518685A5 - - Google Patents
Info
- Publication number
- JP2024518685A5 JP2024518685A5 JP2023560623A JP2023560623A JP2024518685A5 JP 2024518685 A5 JP2024518685 A5 JP 2024518685A5 JP 2023560623 A JP2023560623 A JP 2023560623A JP 2023560623 A JP2023560623 A JP 2023560623A JP 2024518685 A5 JP2024518685 A5 JP 2024518685A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- cancer
- compound
- dose
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2104416.9A GB202104416D0 (en) | 2021-03-29 | 2021-03-29 | Treatment reginmens |
| GB2104416.9 | 2021-03-29 | ||
| GBGB2117511.2A GB202117511D0 (en) | 2021-12-03 | 2021-12-03 | Treatment regimens |
| GB2117511.2 | 2021-12-03 | ||
| PCT/EP2022/058283 WO2022207646A1 (en) | 2021-03-29 | 2022-03-29 | A pi3k-delta inhibitor for use in treatment regimens |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024518685A JP2024518685A (ja) | 2024-05-02 |
| JP2024518685A5 true JP2024518685A5 (https=) | 2025-04-04 |
| JP7839803B2 JP7839803B2 (ja) | 2026-04-02 |
Family
ID=81388915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560623A Active JP7839803B2 (ja) | 2021-03-29 | 2022-03-29 | 治療レジメンで使用するためのｐｉ３ｋ－デルタ阻害剤 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US12605389B2 (https=) |
| EP (1) | EP4313058B1 (https=) |
| JP (1) | JP7839803B2 (https=) |
| AU (1) | AU2022251843B2 (https=) |
| CA (1) | CA3212731A1 (https=) |
| DK (1) | DK4313058T3 (https=) |
| ES (1) | ES3031295T3 (https=) |
| FI (1) | FI4313058T3 (https=) |
| HR (1) | HRP20250516T1 (https=) |
| HU (1) | HUE071610T2 (https=) |
| LT (1) | LT4313058T (https=) |
| MX (1) | MX2023011442A (https=) |
| PL (1) | PL4313058T3 (https=) |
| PT (1) | PT4313058T (https=) |
| RS (1) | RS66754B1 (https=) |
| SI (1) | SI4313058T1 (https=) |
| WO (1) | WO2022207646A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026510567A (ja) * | 2023-03-03 | 2026-04-08 | アイオンクチュラ・ソシエテ・アノニム | 血液悪性腫瘍の治療におけるロギノリシブ及びｂｃｌ－２阻害剤の組み合わせ |
| AU2024231699A1 (en) * | 2023-03-03 | 2025-09-11 | Ionctura Sa | Combination of roginolisib and hdac inhibitor in the treatment of haematological malignancy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201290305A1 (ru) | 2009-11-13 | 2012-12-28 | Мерк Сероно С.А. | Производные трициклического пиразоламина |
| WO2014121901A1 (en) | 2013-02-07 | 2014-08-14 | Merck Patent Gmbh | Polymorphic forms |
| US9986723B2 (en) | 2014-10-22 | 2018-06-05 | The Board Of Regents Of The University Of Texas System | Screen and use of therapeutics for pancreatic ductal adenocarcinoma |
| GB201502020D0 (en) | 2015-02-06 | 2015-03-25 | Cancer Rec Tech Ltd | Autotaxin inhibitory compounds |
| EP3610264A1 (en) | 2017-04-13 | 2020-02-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the diagnosis and treatment of pancreatic ductal adenocarcinoma |
-
2022
- 2022-03-29 WO PCT/EP2022/058283 patent/WO2022207646A1/en not_active Ceased
- 2022-03-29 CA CA3212731A patent/CA3212731A1/en active Pending
- 2022-03-29 AU AU2022251843A patent/AU2022251843B2/en active Active
- 2022-03-29 MX MX2023011442A patent/MX2023011442A/es unknown
- 2022-03-29 HR HRP20250516TT patent/HRP20250516T1/hr unknown
- 2022-03-29 PT PT227192663T patent/PT4313058T/pt unknown
- 2022-03-29 EP EP22719266.3A patent/EP4313058B1/en active Active
- 2022-03-29 DK DK22719266.3T patent/DK4313058T3/da active
- 2022-03-29 HU HUE22719266A patent/HUE071610T2/hu unknown
- 2022-03-29 SI SI202230137T patent/SI4313058T1/sl unknown
- 2022-03-29 FI FIEP22719266.3T patent/FI4313058T3/fi active
- 2022-03-29 PL PL22719266.3T patent/PL4313058T3/pl unknown
- 2022-03-29 LT LTEPPCT/EP2022/058283T patent/LT4313058T/lt unknown
- 2022-03-29 ES ES22719266T patent/ES3031295T3/es active Active
- 2022-03-29 JP JP2023560623A patent/JP7839803B2/ja active Active
- 2022-03-29 US US18/271,196 patent/US12605389B2/en active Active
- 2022-03-29 RS RS20250390A patent/RS66754B1/sr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10590079B2 (en) | Cyano-substituted indoles as LSD1 inhibitors | |
| JP5546717B2 (ja) | アリピプラゾール結晶質形態を調製する方法 | |
| JP7558334B2 (ja) | ＰＩ３Ｋ－γ阻害剤としてのアミノピラジンジオール化合物 | |
| US11225486B2 (en) | Tertiary alcohols as PI3K-γ inhibitors | |
| CN111770914B (zh) | 作为神经激肽-1受体拮抗剂的化合物及其用途 | |
| JP6457658B2 (ja) | 安定した、溶媒和物が含まれないアプレミラスト結晶形ｉｉ、及びその製造方法 | |
| CN110573500A (zh) | N-(氮杂芳基)环内酰胺-1-甲酰胺衍生物及其制备方法和应用 | |
| JP2024518685A5 (https=) | ||
| CA2957466C (en) | Drug combinations to treat multiple myeloma | |
| WO2020239097A1 (zh) | 一种parp抑制剂微丸制剂及其制备工艺 | |
| CN103221411B (zh) | (R)-7-氯-N-(奎宁环-3-基)苯并[b]噻吩-2-甲酰胺盐酸盐单水合物的晶型 | |
| CA2693390A1 (en) | Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same | |
| US20190263799A1 (en) | 1h-imidazo[4,5-b]pyridinyl and 2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridinyl heterocyclic bet bromodomain inhibitors | |
| JP2016504392A (ja) | 抗レトロウイルス剤としての（ヘテロ）アリールアセトアミド誘導体 | |
| JP2011518786A (ja) | 調製及び使用のための組成物及び方法 | |
| JP2022540421A5 (https=) | ||
| JP2013544239A5 (https=) | ||
| JP2021505575A (ja) | 非ラセミ混合物およびその使用 | |
| JP2018531288A5 (https=) | ||
| JP5860895B2 (ja) | ５−メチル−１−（ナフタレン−２−イル）−１ｈ−ピラゾール誘導体 | |
| JP2018529742A5 (https=) | ||
| JP2015510916A5 (https=) | ||
| WO2019224774A1 (en) | Heterocyclic amides as rip1 kinase inhibitors | |
| EP3022201A1 (en) | Autotaxin inhibitors | |
| FI4313058T3 (fi) | Roginolisibia käsittävä koostumus ja annosteluohjelma syövän tai tulehdus- tai autoimmunisairauden hoitoon |